Belvedere Trading’s GoHealth GOCO Stock Holding History

Belvedere Trading’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,827	Closed	-$106K	–	521
2021 Q4	$106K	Sell	2,827 -140	-5%	-$9.34K	﹤0.01%	289
2021 Q3	$243K	Buy	+2,967	New	+$314K	0.01%	222

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Belvedere Trading's GOCO Position: Q1 2022 in Review

Belvedere Trading sold out of GoHealth (GOCO) in Q1 2022, closing a stake of 2,827 shares — an estimated $106K sold.

Belvedere Trading first reported a position in GOCO in Q3 2021 and held it in 2 quarters. The position peaked at $243K in Q3 2021. 112 funds tracked by Wall St. Rank hold GOCO as of Q1 2022.

Belvedere Trading reported no remaining GoHealth position as of Q1 2022 after selling out during the quarter.
Belvedere Trading sold 2,827 GoHealth shares in Q1 2022, an estimated $106K.
Belvedere Trading first reported a position in GoHealth in Q3 2021 and held it in 2 quarters.
Belvedere Trading's GoHealth position peaked at $243K in Q3 2021.
112 funds tracked by Wall St. Rank held GoHealth as of Q1 2022.

Based on Belvedere Trading's 13F filing for Q1 2022, filed 20 Apr 2022.